Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Starting your retirement plan at the right age can make all the difference. Explore the benefits of early retirement planning.
26,459 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
When a space tech company makes a big fundraising move, its stock can swing just as fast. Learn why intuitive machine...
Investors flocked to Ferroglobe after a midweek earnings update, turning a measured bounce into a genuine momentum pl...
Could SpaceX go public and spark a 450% rally? A wall street analyst sees big upside if key growth engines and regula...
BlackBerry is navigating a pivot from legacy devices to software and security. This guide breaks down what to expect ...
A big insider move at a major insurer has analysts and traders watching closely. Learn what assured guaranty’s inside...
Tilray has cleared several hurdles, but a true breakout depends on one pivotal development. This guide breaks down th...
SpaceX has disrupted aerospace, but could spacex become first to reach a $10 trillion valuation? This long-form guide...
Oracle isn't done spending on AI, and the move is shaking up how investors view cloud growth and profitability. This ...
June dealt a sharp blow to crypto portfolios, but history suggests volatility can bring opportunity. This guide expla...
What could Alphabet stock be worth half a decade from now? This article builds scenarios around AI capital spending, ...
A corporate insider sold a meaningful chunk of stock after a record revenue year. This article breaks down what such ...